Jade Biosciences JBIO
NASDAQ JBIO
$14.59 -0.32 (-2.15%)
At close: Oct 23, 2026 · 4:00 PM EDT

Jade Biosciences (JBIO) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Jade Biosciences (JBIO) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Jade Biosciences 927.28 Mn -380.34 Mn - 44.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.69 Mn
Mar 31, 2026 65.43 Mn
Mar 31, 2025 12.85 Mn
Dec 31, 2024 13.13 Mn
Sep 30, 2024 21.00 Mn
Jun 30, 2024 18.00 Mn
Mar 31, 2024 23.58 Mn
Dec 31, 2023 33.50 Mn
Sep 30, 2023 34.75 Mn
Jun 30, 2023 36.75 Mn
Mar 31, 2023 31.00 Mn
Dec 31, 2022 64.75 Mn
Sep 30, 2022 30.25 Mn
Jun 30, 2022 47.23 Mn
Mar 31, 2022 12.52 Mn
API Access

Jade Biosciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=JBIO&period=max&api_key=YOUR_API_KEY